MedTrace Logo

A Feasibility Study to Evaluate the Safety and Effectiveness of Implantation of Flowise Cerebral Flow Diverter (Flowise)

NCT02609867 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2019-07-05

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and short-term effectiveness of implantation of 'Flowise Cerebral Flow Diverter' for the treatment of unruptured wide-necked cerebral aneurysm in the internal carotid artery.

Conditions

  • Intracranial Aneurysm

Interventions

DEVICE

Flowise Cerebral Flow Diverter

Flowise Cerebral Flow Diverter Placement

Sponsors & Collaborators

  • Yonsei University

    lead OTHER

Principal Investigators

  • Buyng Moon Kim, PhD. MD · Yonsei University Healthcare System, Severance Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-23
Primary Completion
2018-01-22
Completion
2018-01-22

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02609867 on ClinicalTrials.gov